Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
ID06938295

Comparing Diagnostic Accuracy of High-End Intestinal Ultrasound Versus Mid-End Ultrasound With Tandem Ileo-Colonoscopy in Inflammatory Bowel Disease (The HUMID Study): A Paired, Validating Confirmatory Study

Led by Asian Institute of Gastroenterology, India · Updated on 2025-07-16

500

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the diagnostic accuracy of two different intestinal ultrasound machines—a high-end system (Samsung RS85) and a mid-end system (Siemens ACUSON S2000)—in detecting ileocolonic inflammation in patients with inflammatory bowel disease (IBD). This prospective, cross-sectional study uses ileo-colonoscopy as the reference standard and aims to determine if the more affordable mid-end machine can provide comparable results to the advanced high-end equipment. The study also looks at how ultrasound findings influence clinical management decisions and potential cost savings in healthcare settings with limited resources. Participants undergo two intestinal ultrasound examinations in the same session, one with each machine, performed by different specialists who are blinded to each other's results and colonoscopy findings. Ultrasound assessments measure bowel wall thickness, vascularity, and other disease markers. Within 24 hours, participants also have an ileo-colonoscopy to confirm disease activity. An independent panel reviews ultrasound findings to decide if treatment changes are justified. The study includes an economic analysis to assess cost-effectiveness of using mid-end ultrasound in routine care. During the study, participants receive clinical evaluation, two ultrasound scans, and a colonoscopy all within a short timeframe. Data collected includes detailed ultrasound and endoscopy results recorded on case report forms. Researchers measure diagnostic accuracy using sensitivity, specificity, positive predictive value, and negative predictive value. They also track changes in clinical management based on ultrasound findings. The total participation involves a single-day assessment, with results informing potential improvements in IBD diagnostic practices.

CONDITIONS

Brief Title

Comparing Diagnostic Accuracy of High-end Intestinal Ultrasound Versus Mid-end Ultrasound With Tandem Ileo-colonoscopy in Inflammatory Bowel Disease : a Paired, Validating Confirmatory Study

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 18-75 years
  • Confirmed diagnosis of inflammatory bowel disease with ileocolonic involvement
  • Clinically stable at the time of assessment
  • Willing and able to undergo both mid-end and high-end intestinal ultrasound assessments
  • Willing and able to undergo ileo-colonoscopy
  • Provides informed consent to participate
Not Eligible

You will not qualify if you...

  • Pregnant or breastfeeding individuals
  • Patients with contraindications to ileo-colonoscopy, such as severe comorbidities or known intolerance
  • Individuals unable to provide informed consent
  • Patients with conditions interfering with ultrasound imaging, such as severe obesity or uncooperative behavior

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - 1 day

Participants undergo two intestinal ultrasound examinations using a high-end and a mid-end ultrasound machine in the same session to assess ileocolonic inflammation, followed by an ileo-colonoscopy within 24 hours as the reference standard.

1 visit including both ultrasound examinations and ileo-colonoscopy (in-person)

Surveillance

Duration - Within 24 hours after diagnostic evaluation

An independent physician panel reviews ultrasound findings within 24 hours to determine potential changes in clinical management based on the diagnostic results.

No additional visits required

Trial Site Locations

Total: 1 location

1

Asian Institute of Gastroenterology

Hyderabad, Telangana, India, 500082

Actively Recruiting

Loading map...

Research Team

P

Partha Pal, MD, DNB, MRCP (UK), FASGE

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Similar Trials

A Phase 1, First-In-Human Study to Evaluate the Safety, Tole...

Inflammatory Bowel Disease (IBD)

Actively Recruiting

1 location

A Phase 2, Multi-Center, Platform Study to Evaluate the Safe...

Inflammatory Bowel Disease (IBD)

Actively Recruiting

66 locations

Post-Marketing Surveillance of Vedolizumab Subcutaneous Inje...

Ulcerative Colitis

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

High-end intestinal ultrasound versus mid-end systems benchmarked against tandem ileocolonoscopy in inflammatory bowel disease (HUMID): a paired prospective, validating confirmatory study.

Partha Pal, Mohammad Abdul Mateen, Syed Misba Naaz...

https://pubmed.ncbi.nlm.nih.gov/41969335